COMMUNIQUÉS West-GlobeNewswire

Kaleido Biosciences Announces Appointment of Jean Mixer to its Board of Directors
30/09/2019
LEXINGTON, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and [...]
Intra-Cellular Therapies to Present at the 2019 Cantor Global Healthcare Conference
30/09/2019
NEW YORK, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
CymaBay Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
30/09/2019
NEWARK, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]
Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference and Chardan's 3rd Annual Genetic Medicines Conference
30/09/2019
PITTSBURGH, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]
BioSig to Present Clinical Observations at Venice Arrhythmias 2019
30/09/2019
Poster presentation to highlight initial clinical data collected with PURE EP(tm) System Westport, CT, Sept. 30, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company developing [...]
Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK 51.8 million
30/09/2019
Press release Malmö, 30 September 2019 Acarix publish EU growth prospectus in connection with rights issue of up to approximately SEK 51.8 million The board of directors of Acarix AB ("Acarix" or the "Company") resolved [...]
T2 Biosystems’ T2Resistance™ Panel is Now Available as a Research Use Only (RUO) Test in the U.S.
30/09/2019
Panel is the only direct-from-blood diagnostic designed to detect genetic markers associated with antibiotic-resistant bloodstream infections LEXINGTON, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. ( [...]
Idera Pharmaceuticals Announces Initiation of the ILLUMINATE-206 Trial Evaluating Tilsotolimod in Combination with Nivolumab and Ipilimumab for the Treatment of Solid Tumors
30/09/2019
EXTON, Pa., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced today the initiation of a phase 2 trial, ILLUMINATE-206 which will evaluate tilsotolimod, a toll-like receptor 9 (TLR9 [...]
Translate Bio to Present at the 3rd Annual Chardan Genetic Medicines Conference
30/09/2019
LEXINGTON, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Checkpoint Therapeutics Announces Presentation of Positive Interim Clinical Results for Anti-PD-L1 Cosibelimab at the European Society for Medical Oncology (ESMO) Congress 2019
30/09/2019
50% objective response rate observed in cutaneous squamous cell carcinoma (CSCC) 40% objective response rate observed in non-small cell lung cancer Well-tolerated safety profile across all cohorts Enrollment ongoing to [...]
Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
30/09/2019
BETonMACE did not meet the primary endpoint Apabetalone development to continue to be advanced by the Company based on BETonMACE results Primary results to be presented during a late-breaking science session at AHA 2019 [...]
Syneos Health Introduces New Book, Why We Resist: The Surprising Truths About Motivating Behavior Change
30/09/2019
Syneos Health Behavioral Scientist and Expert Communicator Team Up to Author Behavioral Insights Book – Proceeds Donated to The STARR Coalition MORRISVILLE, N.C., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Syneos Health ® ( [...]
TG Therapeutics Announces Publication of Clinical Data from the Phase I/Ib Combination Trial of Ublituximab and Umbralisib (“U2”) in Blood
30/09/2019
U2 combination was generally well-tolerated with relatively low rates of immune-mediated toxicities Combination treatment resulted in median progression free survival (PFS) of ~28 months in relapsed/refractory chronic [...]
CK Hutchison offers 1.3% of Chi-Med’s share capital aiming to deconsolidate and hold Chi-Med as a strategic investment for the long term
30/09/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION LONDON, Sept. 30, 2019 (GLOBE [...]
Aptinyx to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
30/09/2019
EVANSTON, Ill., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Orchard Therapeutics Announces Presentation of New Clinical Data for OTL-200 for Metachromatic Leukodystrophy at Upcoming European Society of Gene & Cell Therapy Annual Congress
30/09/2019
Initial Results from Cryopreserved Formulation Clinical Trial Accepted as Poster Presentation BOSTON and LONDON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage [...]
ProQR to Present at Two Investor Conferences in October
30/09/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
R1 RCM to Present at the Cantor Fitzgerald 2019 Global Healthcare Conference
30/09/2019
CHICAGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leader in technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced the company will present at the [...]
Scilex Holding Company Strengthens Board of Directors with Appointment of Two Highly Accomplished Pharmaceutical and Biotechnology Executives, Scott Whitcup, M.D. and Elizabeth Czerepak
30/09/2019
PALO ALTO, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Scilex Holding Company (Scilex) today announced that it appointed Scott M. Whitcup, M.D. as lead independent director to its Board of Directors in May of this year. [...]

Pages